Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Peerapat Technology PCLBKK:PRAPAT-R 73 Capex-to-Operating-Income is 2.01 as of Jun. 2026, which is 7% above its 10-year median of 1.87. GuruFocus rates BKK:PRAPAT-R with a GF Score™ of 73/100 and a GF Value™ of ฿1.24 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 919 Chemicals companies, Peerapat Technology PCL ranks worse than 82.59% on this metric.
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
Peerapat Technology PCL Capex-to-Operating-Income Related Terms
Peerapat Technology PCL Capex-to-Operating-Income Historical Data
* Premium members only.
The historical data trend for Peerapat Technology PCL's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:PRAPAT-R vs LIN, SHW, ECL: Capex-to-Operating-Income Comparison
For the Specialty Chemicals subindustry, Peerapat Technology PCL's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peerapat Technology PCL Capex-to-Operating-Income vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Peerapat Technology PCL's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where Peerapat Technology PCL's Capex-to-Operating-Income falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Income of 2.01 mean?
Peerapat Technology PCL (BKK:PRAPAT-R) has a Capex-to-Operating-Income of 2.01 as of Jun. 2026. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on Peerapat Technology PCL and its competitors. This is near median its historical median of 1.87. Over the past decade, Peerapat Technology PCL's Capex-to-Operating-Income has ranged from 1.38 to 5.06. According to the industry distribution chart, Peerapat Technology PCL ranks #759 out of 919 companies in the Chemicals industry, placing it in the top 82.6%.
Is Peerapat Technology PCL's Capex-to-Operating-Income too high?
Peerapat Technology PCL's current Capex-to-Operating-Income of 2.01 is near median its 10-year median of 1.87. Over the past 10 years, this metric has ranged from a low of 1.38 to a high of 5.06. The Chemicals industry median Capex-to-Operating-Income is 0.60. Peerapat Technology PCL's value of 2.01 is 235% above this industry median. Based on the distribution chart, Peerapat Technology PCL ranks #759 out of 919 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Peerapat Technology PCL has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Peerapat Technology PCL's Capex-to-Operating-Income compare to LIN and SHW?
According to the Chemicals industry distribution chart, Peerapat Technology PCL ranks #759 out of 919 companies for Capex-to-Operating-Income. This places Peerapat Technology PCL in the lower half of its industry. The industry median Capex-to-Operating-Income is 0.60. Peerapat Technology PCL's value of 2.01 is 235% above this benchmark. Historically, Peerapat Technology PCL's own Capex-to-Operating-Income has ranged from 1.38 to 5.06 over the past decade. While the company's 10-year median is 1.87 vs. the industry median of 0.60, Peerapat Technology PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Income for a Chemicals company?
The median Capex-to-Operating-Income among Chemicals companies is 0.60, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Income significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peerapat Technology PCL's current Capex-to-Operating-Income of 2.01 is 235% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Income mean?
A high Capex-to-Operating-Income can signal that a stock is expensive relative to its fundamentals. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on Peerapat Technology PCL and its competitors. For the Chemicals industry, the median Capex-to-Operating-Income is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peerapat Technology PCL's current Capex-to-Operating-Income is 2.01, which is near median its own 10-year median of 1.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peerapat Technology PCL stock overvalued right now?
Based on GuruFocus' analysis, Peerapat Technology PCL (BKK:PRAPAT-R) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.24, compared to a current price of ฿0.91 — trading 26.7% below its estimated fair value. The current Capex-to-Operating-Income is 2.01, which is near median its 10-year median of 1.87 and 235% above the Chemicals industry median of 0.60. Peerapat Technology PCL's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Income calculated?
Capex-to-Operating-Income is calculated from a company's financial statements. For Peerapat Technology PCL (BKK:PRAPAT-R), the current Capex-to-Operating-Income is 2.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Peerapat Technology PCL (BKK:PRAPAT-R) Overvalued in 2026?
Based on GuruFocus' analysis, Peerapat Technology PCL stock appears to be undervalued.
The current stock price of ฿0.91 is trading 26.7% below its estimated GF Value™ of ฿1.24.
GuruFocus considers Peerapat Technology PCL to be Modestly Undervalued.
Key valuation signals for BKK:PRAPAT-R:
Capex-to-Operating-Income: 2.01 (near median its 10-year median of 1.87)
GF Value™: ฿1.24 vs. price of ฿0.91 (26.7% below fair value)
Industry Position: 235% above the Chemicals median (#759 of 919)
No single metric tells the full story. See the BKK:PRAPAT-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Peerapat Technology PCL is principally engaged in the manufacture and distribution of powdered detergent and cleaning chemicals for industrial use, the distribution of energy-saving equipment, the distribution and rental of dishwashers, the distribution of swimming pools, and the provision of related services. The Group is organised into business units based on its products and services and has four reportable segments: Manufacture and distribution of cleaning chemicals segment, Distribution of energy saving equipment and services segment, Distribution of kitchen products and services segment, and Distribution of swimming pool products and services segment. The majority of its revenue is generated from the Manufacture and distribution of cleaning chemicals segment.
73GF Score
Get the complete analysis for BKK:PRAPAT-R
Capex-to-Operating-Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:PRAPAT-R has been successfully added to your 
